Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Health and Healthcare

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

587 Articles

Chris Lange | May 29, 2016 at 10:15 AM EDT

Key Movers to Look for Ahead of ASCO

The American Society of Clinical Oncology (ASCO) is gearing up for its annual meeting. At this meeting, cancer drug developers…

Lee Jackson | May 25, 2016 at 10:05 AM EDT

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

Despite the ongoing political candidate chirping, all of these quality big pharmaceutical stocks have been around, and they will continue…

Chris Lange | May 25, 2016 at 8:15 AM EDT

Short Sellers Take Mixed Stance on Major Pharma

The May 13 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Chris Lange | May 19, 2016 at 10:20 AM EDT

8 Stocks on the Move After ASCO Cancer Abstracts

ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or…

Chris Lange | May 11, 2016 at 8:45 AM EDT

Major Pharma Short Interest Continues to Recede

The short interest data have been released for the April 29 settlement date, and for most of the selected pharmaceutical…

Chris Lange | Apr 28, 2016 at 9:20 AM EDT

Bristol-Myers Squibb Offers Up Solid Earnings Beat and Lifts Guidance

Bristol-Myers Squibb released better-than-expected first-quarter financial results before the markets opened on Thursday.

Chris Lange | Apr 27, 2016 at 9:15 AM EDT

Major Pharma Short Interest Remains Mixed, With 1 Massive Drop

The April 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Apr 12, 2016 at 9:50 AM EDT

Short Sellers Become More Selective in Major Pharma

The March 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Lee Jackson | Mar 30, 2016 at 11:05 AM EDT

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the…

Chris Lange | Mar 15, 2016 at 9:25 AM EDT

Jefferies Top Drug Stocks for the Rest of 2016

For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made…

Chris Lange | Mar 10, 2016 at 8:40 AM EST

Major Pharma Short Interest Takes a Small Step Back

The February 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…

Chris Lange | Feb 25, 2016 at 8:10 AM EST

Short Sellers Increase Bets in Major Pharma

The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Chris Lange | Feb 10, 2016 at 9:15 AM EST

Short Sellers Increase Bets in Major Pharma

The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Chris Lange | Jan 28, 2016 at 8:40 AM EST

Short Sellers Become More Selective on Major Pharma

The January 15 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Chris Lange | Jan 13, 2016 at 9:15 AM EST

Major Pharma Short Sellers Increase Bets

The short interest data have been released for the December 31 settlement date. For most of the selected pharmaceutical stocks…

1 … 23 24 25 26 27 … 40

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Key Movers to Look for Ahead of ASCO

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

Short Sellers Take Mixed Stance on Major Pharma

8 Stocks on the Move After ASCO Cancer Abstracts

Major Pharma Short Interest Continues to Recede

Bristol-Myers Squibb Offers Up Solid Earnings Beat and Lifts Guidance

Major Pharma Short Interest Remains Mixed, With 1 Massive Drop

Short Sellers Become More Selective in Major Pharma

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

Jefferies Top Drug Stocks for the Rest of 2016

Major Pharma Short Interest Takes a Small Step Back

Short Sellers Increase Bets in Major Pharma

Short Sellers Increase Bets in Major Pharma

Short Sellers Become More Selective on Major Pharma

Major Pharma Short Sellers Increase Bets

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Trump and Warsh Plot Chaotic Stock Market Strategy for June

Apple Might Haven Taken Aim at OpenAI with New Announcement. There’s Only One Problem.

Warren Buffett’s $400 Billion Is Going Nowhere for Now: Here’s Why Berkshire Hathaway Is My Top Pick for the Next 20 Years

Retiring at the Coast Comes With a $9,800 Annual Insurance Shock

How a 401(k) Balance Over $1 Million Quietly Pushes 85 Percent of a Couple's Social Security Into the Taxable Zone

Trump and Warsh Plot Chaotic Stock Market Strategy for June

Apple Might Haven Taken Aim at OpenAI with New Announcement. There’s Only One Problem.

Bristol Myers Squibb : BMY

All Bristol Myers Squibb Articles

Key Movers to Look for Ahead of ASCO

4 UBS Most Preferred Pharmaceutical Stocks That Pay Big Dividends

Short Sellers Take Mixed Stance on Major Pharma

8 Stocks on the Move After ASCO Cancer Abstracts

Major Pharma Short Interest Continues to Recede

Bristol-Myers Squibb Offers Up Solid Earnings Beat and Lifts Guidance

Major Pharma Short Interest Remains Mixed, With 1 Massive Drop

Short Sellers Become More Selective in Major Pharma

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

Jefferies Top Drug Stocks for the Rest of 2016

Major Pharma Short Interest Takes a Small Step Back

Short Sellers Increase Bets in Major Pharma

Short Sellers Increase Bets in Major Pharma

Short Sellers Become More Selective on Major Pharma

Major Pharma Short Sellers Increase Bets

Stock Market Live June 10, 2026: S&P 500 (SPY) Sinks on Fear of War

Trump and Warsh Plot Chaotic Stock Market Strategy for June

Apple Might Haven Taken Aim at OpenAI with New Announcement. There’s Only One Problem.

Warren Buffett’s $400 Billion Is Going Nowhere for Now: Here’s Why Berkshire Hathaway Is My Top Pick for the Next 20 Years

Featured Reads

Retiring at the Coast Comes With a $9,800 Annual Insurance Shock

How a 401(k) Balance Over $1 Million Quietly Pushes 85 Percent of a Couple's Social Security Into the Taxable Zone